Sign in

You're signed outSign in or to get full access.

Cronos Group (CRON)

--

Earnings summaries and quarterly performance for Cronos Group.

Research analysts who have asked questions during Cronos Group earnings calls.

Recent press releases and 8-K filings for CRON.

Cronos Group Inc. to Acquire CanAdelaar, Expanding into European Cannabis Market
CRON
M&A
New Projects/Investments
Revenue Acceleration/Inflection
  • Cronos Group Inc. (CRON) announced it will acquire CanAdelaar B.V., the largest adult-use cannabis company operating within the Netherlands' adult-use cannabis pilot program, for an up-front cash consideration of US$67.0 million (€57.5 million).
  • The acquisition includes additional contingent cash consideration payable based on 0.5x CanAdelaar's normalized EBITDA in 2026 and 2027.
  • This transaction is expected to provide Cronos with the #1 market share in Europe's largest adult-use cannabis market.
  • CanAdelaar reported revenue of US$47.3 million and EBITDA of US$28.2 million for the twelve months ended September 30, 2025.
  • The acquisition is anticipated to close in the first half of 2026.
Dec 9, 2025, 12:32 PM
Cronos Announces Acquisition of CanAdelaar
CRON
M&A
New Projects/Investments
  • Cronos Group Inc. announced its wholly-owned subsidiary will acquire CanAdelaar B.V. for an up-front cash consideration of US$67.0 million (or €57.5 million), with additional contingent consideration based on 0.5x CanAdelaar's normalized EBITDA in 2026 and 2027.
  • CanAdelaar is the largest cannabis company operating within the Netherlands' adult-use cannabis pilot program, the Wietexperiment, and the acquisition is expected to give Cronos the #1 market share in Europe's largest adult-use cannabis market.
  • The acquisition provides a strategic footprint in Europe, enabling Cronos to leverage its investments in genetics and R&D through a borderless product strategy.
  • CanAdelaar generated US$17.7 million in revenue and US$8.0 million in EBITDA in 2024, growing to US$47.3 million in revenue and US$28.2 million in EBITDA for the twelve months ended September 30, 2025.
  • The transaction is expected to close in early 2026, subject to customary closing conditions and regulatory clearances.
Dec 9, 2025, 12:30 PM
Cronos Group Reports Record Q3 2025 Net Revenue and Improved Profitability
CRON
Earnings
Revenue Acceleration/Inflection
New Projects/Investments
  • Cronos Group reported consolidated net revenue of $36.3 million in Q3 2025, marking a 6% increase year over year, primarily driven by strong cannabis flower sales in Israel and extract sales in Canada.
  • The company achieved a gross profit of $18.3 million, equating to a 50% gross margin, a 19 percentage point improvement from Q3 2024, and Adjusted EBITDA of $5.7 million, an $11.7 million year-over-year improvement.
  • Cronos Group maintains a strong financial position with $824 million in cash, cash equivalents, and short-term investments as of Q3 2025.
  • The phase two expansion at GrowCo is complete, with flower sales starting in fall 2025, and is anticipated to drive improved flower sales in 2026 due to a 70% capacity increase.
Nov 6, 2025, 1:30 PM
Cronos Group Reports Record Q3 2025 Net Revenue, Gross Profit, and Adjusted EBITDA
CRON
Earnings
Revenue Acceleration/Inflection
New Projects/Investments
  • Cronos Group Inc. achieved record levels of consolidated net revenue, gross profit, and Adjusted EBITDA in Q3 2025. Net revenue increased by 9% quarter-over-quarter and 6% year-over-year to $36.3 million.
  • The company reported a gross profit of $18.3 million and Adjusted EBITDA of $5.7 million in Q3 2025, representing increases of $14.7 million and $11.7 million respectively, compared to Q3 2024.
  • Cronos maintains a strong balance sheet with $824 million in total cash and cash equivalents and short-term investments as of September 30, 2025.
  • Israel generated record-high net revenue, with the PEACE NATURALS® brand remaining the number one cannabis brand in the market. In Canada, the Spinach® brand held the #2 overall market share, leading the edibles category with a 19.7% market share and ranking #3 in vapes with a 7.0% share.
  • The Cronos GrowCo expansion is complete, with sales commencing in Fall 2025, expected to fuel growth in 2026.
Nov 6, 2025, 12:32 PM
Trump Media, Crypto.com, and Yorkville Launch CRO Treasury Company
CRON
New Projects/Investments
Debt Issuance
  • Trump Media Group, in partnership with Crypto.com and Yorkville Acquisition Corp., has launched Trump Media Group CRO Strategy Inc., a $6.42 billion digital asset treasury company focused exclusively on the Cronos (CRO) token, which will be publicly traded under the ticker MCGA.
  • The company aims to build a treasury of at least $6.42 billion, funded by $1 billion in CRO tokens, $420 million in cash and warrants, and a $5 billion equity line of credit from YA II PN, Ltd..
  • Trump Media will run a validator node on the Cronos blockchain, stake its CRO holdings to generate additional revenue, and integrate CRO into its Truth Social platform through a new rewards system that allows users to convert platform points into CRO tokens, with future plans for subscription payments and discounted services using CRO.
  • Founding shareholders have agreed to a one-year lock-up period followed by a three-year release schedule, highlighting a long-term commitment to the initiative.
Aug 26, 2025, 12:46 PM